Enzyme‐Triggered Intestine‐Specific Targeting Adhesive Platform for Universal Oral Drug Delivery
Advanced Healthcare Materials · 2023-10 · 12 (27)
DOI: 10.1002/adhm.202301033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.06.2023. Verfasst von Ying Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Haidian District, Beijing, 100193, P.…. Hauptthemen laut MEDLINE: Adhesives, Drug Delivery Systems. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Massachusetts Institute of Technology, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Patient adherence to chronic therapies can be suboptimal, leading to poor therapeutic outcomes. Dosage forms that enable reduction in dosing frequency stand to improve patient adherence. Variation in gastrointestinal transit time, inter‐individual differences in gastrointestinal physiology and differences in physicochemical properties of drugs represent challenges to the development of such systems. To this end, a small intestine‐targeted drug delivery system is developed, where prolonged gastrointestinal retention and sustained release are achieved through tissue adhesion of drug pills mediated by an essential intestinal enzyme catalase. Here proof‐of‐concept pharmacokinetics is demonstrated in the swine model for two drugs, hydrophilic amoxicillin and hydrophobic levodopa. It is anticipated that this system can be applicable for many drugs with a diverse of physicochemical characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Haidian District, Beijing, 100193, P. R. China.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, 16419, South Korea.
- Department of Biomedical Engineering, Sungkyunkwan University, Suwon, 16419, South Korea.
- Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- Faculty of Applied Science & Engineering, University of Toronto, Toronto, ON, M5S1A4, Canada.
ORCID-Profile: Ying Li
Förderung
- China Scholarship Council
- Massachusetts Institute of Technology
- Bill and Melinda Gates Foundation
Zitieren
APA
Li, Y., Lee, J. S., Kirtane, A. R., Li, M., Coffey, C. W., Hess, K., Lopes, A., Collins, J., Tamang, S., Ishida, K., Hayward, A., Wainer, J., Wentworth, A. J., & Traverso, G. (2023). Enzyme‐Triggered Intestine‐Specific Targeting Adhesive Platform for Universal Oral Drug Delivery. Advanced Healthcare Materials, 12(27). https://doi.org/10.1002/adhm.202301033
Vancouver
Li Y, Lee JS, Kirtane AR, Li M, Coffey CW, Hess K, et al. Enzyme‐Triggered Intestine‐Specific Targeting Adhesive Platform for Universal Oral Drug Delivery. Advanced Healthcare Materials. 2023;12(27). doi:10.1002/adhm.202301033
BibTeX
@article{Li2023,
author = {Li, Ying and Lee, Jung Seung and Kirtane, Ameya R and Li, Mengyuan and Coffey, Charles William and Hess, Kaitlyn and Lopes, Aaron and Collins, Joy and Tamang, Siddartha and Ishida, Keiko and Hayward, Alison and Wainer, Jacob and Wentworth, Adam J and Traverso, Giovanni},
title = {Enzyme‐Triggered Intestine‐Specific Targeting Adhesive Platform for Universal Oral Drug Delivery},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {27},
doi = {10.1002/adhm.202301033}
}
EUVIMED